Labeler
Upsher-Smith Laboratories, LLC NDC Codes
Upsher-Smith Laboratories, LLC lists 221 finished drug products in the FDA NDC Directory under NDC labeler codes 0245, 0832, 24979, 80789.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Fluphenazine Hydrochloride, Zestril, Kymbee, Deflazacort, Tadalafil, Dicyclomine Hydrochloride, Torpenz, Isotretinoin, Naprelan, Tenormin, Naproxen Sodium, Galantamine, Pitavastatin, Diltiazem Hydrochloride, Fluvoxamine Maleate
- Active ingredients
- Deflazacort, Fluphenazine hydrochloride, Naproxen sodium, Potassium chloride, Lisinopril, Tadalafil, Dicyclomine hydrochloride, Everolimus, Isotretinoin, Brimonidine tartrate, Atenolol, Galantamine hydrobromide
- NDC labeler codes
- 0245, 0832, 24979, 80789
- Strengths (from the 100 most recently listed products)
- Potassium chloride 750 mg/1; Naproxen sodium 375 mg/1; Naproxen sodium 500 mg/1; Naproxen sodium 750 mg/1; Potassium chloride 600 mg/1; Deflazacort 6 mg/1; Deflazacort 18 mg/1; Deflazacort 30 mg/1; Deflazacort 36 mg/1; Bupropion hydrochloride 450 mg/1; Dicyclomine hydrochloride 20 mg/1; Dicyclomine hydrochloride 10 mg/1; Fluphenazine hydrochloride 1 mg/1; Fluphenazine hydrochloride 5 mg/1; Fluphenazine hydrochloride 10 mg/1; Fluphenazine hydrochloride 2.5 mg/1; Deflazacort 22.75 mg/mL; Fluvoxamine maleate 150 mg/1; Fluvoxamine maleate 100 mg/1; Cyclosporine .5 mg/mL
- Dosage forms
- Tablet, Tablet, Film coated, Tablet, Film coated, Extended release, Tablet, Extended release, Capsule, Extended release, Capsule, Capsule, Delayed release, Capsule, Liquid filled, Solution/ drops, Suspension, Emulsion, Injection, Solution, Solution, Tablet, Delayed release, Powder, For suspension, For solution
- Routes
- Oral, Ophthalmic, Subcutaneous, Auricular (Otic)
- Drug classes (FDA established)
- Corticosteroid, Phenothiazine, Kinase Inhibitor, Nonsteroidal Anti-inflammatory Drug, Osmotic Laxative, Potassium Salt, Angiotensin Converting Enzyme Inhibitor, beta-Adrenergic Blocker, Phosphodiesterase 5 Inhibitor, Anticholinergic, mTOR Inhibitor Immunosuppressant, Retinoid, Serotonin Reuptake Inhibitor, alpha-Adrenergic Agonist, Cholinesterase Inhibitor, HMG-CoA Reductase Inhibitor, Calcium Channel Blocker, Mood Stabilizer, Fluoroquinolone Antibacterial, Aromatase Inhibitor, Anti-epileptic Agent, Aminoketone, Proton Pump Inhibitor, Antimetabolite Immunosuppressant, Calcineurin Inhibitor Immunosuppressant, Histamine-2 Receptor Antagonist, Aminosalicylate, Melatonin Receptor Agonist
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 138 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Paceroneamiodarone hydrochloride | Amiodarone hydrochloride 400 mg/1 | TabletOral | 0245-1645 | 00245-1645-0100245-1645-30 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 225 mg/1 | Capsule, Extended releaseOral | 0832-0740 | 00832-0740-60 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 325 mg/1 | Capsule, Extended releaseOral | 0832-0741 | 00832-0741-60 | — |
| Propafenone Hydrochloride | Propafenone hydrochloride 425 mg/1 | Capsule, Extended releaseOral | 0832-0742 | 00832-0742-60 | — |
| Ethacrynic Acid | Ethacrynic acid 25 mg/1 | TabletOral | 0832-1690 | 00832-1690-1100832-1690-30 | — |
| Haloperidol | Haloperidol .5 mg/1 | TabletOral | 0832-1510 | 00832-1510-11 | — |
| Haloperidol | Haloperidol 1 mg/1 | TabletOral | 0832-1520 | 00832-1520-0100832-1520-11 | — |
| Haloperidol | Haloperidol 2 mg/1 | TabletOral | 0832-1530 | 00832-1530-11 | — |
| Haloperidol | Haloperidol 5 mg/1 | TabletOral | 0832-1540 | 00832-1540-0100832-1540-11 | — |
| Haloperidol | Haloperidol 10 mg/1 | TabletOral | 0832-1550 | 00832-1550-0100832-1550-11 | — |
| Haloperidol | Haloperidol 20 mg/1 | TabletOral | 0832-1560 | 00832-1560-11 | — |
| Testosterone | Testosterone 16.2 mg/g | GelTransdermal | 24979-078 | — | — |
| Morphine Sulfate | Morphine sulfate 15 mg/1 | TabletOral | 0832-0273 | 00832-0273-11 | — |
| Morphine Sulfate | Morphine sulfate 30 mg/1 | TabletOral | 0832-0274 | 00832-0274-11 | — |
| Tosymrasumatriptan | Sumatriptan 10 mg/.1mL | SprayNasal | 0245-0812 | 00245-0812-61 | — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 15 mg/1 | Capsule, Extended releaseOral | 24979-035 | 24979-0035-04 | — |
| Cyclobenzaprine Hydrochloride | Cyclobenzaprine hydrochloride 30 mg/1 | Capsule, Extended releaseOral | 24979-036 | 24979-0036-04 | — |
| Clobazam | Clobazam 20 mg/1 | TabletOral | 0832-0581 | 00832-0581-11 | — |
| Clobazam | Clobazam 10 mg/1 | TabletOral | 0832-0580 | 00832-0580-11 | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 120 mg/1 | Capsule, Extended releaseOral | 24979-026 | 24979-0026-0024979-0026-0224979-0026-06+1 more | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 180 mg/1 | Capsule, Extended releaseOral | 24979-027 | 24979-0027-0024979-0027-0224979-0027-06+1 more | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 240 mg/1 | Capsule, Extended releaseOral | 24979-028 | 24979-0028-0024979-0028-0224979-0028-06+1 more | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 300 mg/1 | Capsule, Extended releaseOral | 24979-029 | 24979-0029-0024979-0029-0224979-0029-06+1 more | — |
| Diltiazem Hydrochloride | Diltiazem hydrochloride 360 mg/1 | Capsule, Extended releaseOral | 24979-030 | 24979-0030-0024979-0030-07 | — |
| Vigadronevigabatrin | Vigabatrin 50 mg/mL | Powder, For solutionOral | 0245-0556 | 00245-0556-50 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 4 mg/1 | TabletOral | 0832-1358 | 00832-1358-11 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 8 mg/1 | TabletOral | 0832-1359 | 00832-1359-11 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 1 mg/1 | TabletOral | 0832-0356 | 00832-0356-11 | — |
| Doxazosindoxazosin mesylate | Doxazosin mesylate 2 mg/1 | TabletOral | 0832-0357 | 00832-0357-11 | — |
| Bumetanide | Bumetanide .5 mg/1 | TabletOral | 0832-0540 | — | — |
| Bumetanide | Bumetanide 1 mg/1 | TabletOral | 0832-0541 | 00832-0541-1000832-0541-11 | — |
| Bumetanide | Bumetanide 2 mg/1 | TabletOral | 0832-0542 | 00832-0542-1000832-0542-11 | — |
| Klor-Conpotassium chloride | Potassium chloride 1.5 g/1 | Powder, For solutionOral | 0245-0360 | 00245-0360-0100245-0360-30 | — |
| Guanfacine Extended-Releaseguanfacine | Guanfacine 1 mg/1 | Tablet, Extended releaseOral | 24979-533 | 24979-0533-0024979-0533-0124979-0533-10 | — |
| Guanfacine Extended-Releaseguanfacine | Guanfacine 2 mg/1 | Tablet, Extended releaseOral | 24979-534 | 24979-0534-0024979-0534-0124979-0534-10 | — |
| Guanfacine Extended-Releaseguanfacine | Guanfacine 3 mg/1 | Tablet, Extended releaseOral | 24979-536 | 24979-0536-0024979-0536-0124979-0536-10 | — |
| Guanfacine Extended-Releaseguanfacine | Guanfacine 4 mg/1 | Tablet, Extended releaseOral | 24979-538 | 24979-0538-0024979-0538-0124979-0538-10 | — |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone bitartrate 5 mg/1; Acetaminophen 325 mg/1 | TabletOral | 0245-0410 | 00245-0410-0100245-0410-1100245-0410-50 | — |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone bitartrate 7.5 mg/1; Acetaminophen 325 mg/1 | TabletOral | 0245-0411 | 00245-0411-0100245-0411-1100245-0411-50 | — |
| Hydrocodone Bitartrate and Acetaminophen | Hydrocodone bitartrate 10 mg/1; Acetaminophen 325 mg/1 | TabletOral | 0245-0412 | 00245-0412-0100245-0412-1100245-0412-50 | — |
| Methimazole | Methimazole 5 mg/1 | TabletOral | 0832-6072 | 00832-6072-11 | — |
| Methimazole | Methimazole 10 mg/1 | TabletOral | 0832-6073 | 00832-6073-11 | — |
| Isotretinoin | Isotretinoin 30 mg/1 | Capsule, Liquid filledOral | 0832-8303 | 00832-8303-30 | — |
| Memantine Hydrochloride | Memantine hydrochloride 5 mg/1 | Tablet, Film coatedOral | 0832-1112 | 00832-1112-60 | — |
| Memantine Hydrochloride | Memantine hydrochloride 10 mg/1 | Tablet, Film coatedOral | 0832-1113 | 00832-1113-60 | — |
| Donepezil Hydrochloride | Donepezil hydrochloride 23 mg/1 | Tablet, Film coatedOral | 24979-004 | 24979-0004-0624979-0004-07 | — |
| Megestrol Acetate | Megestrol acetate 125 mg/mL | SuspensionOral | 24979-041 | 24979-0041-1324979-0041-35 | — |
| Nifedipine | Nifedipine 90 mg/1 | Tablet, Extended releaseOral | 24979-009 | 24979-0009-12 | — |
| Nifedipine | Nifedipine 90 mg/1 | Tablet, Extended releaseOral | 24979-009 | 24979-0009-01 | — |
| Nifedipine | Nifedipine 60 mg/1 | Tablet, Extended releaseOral | 24979-010 | 24979-0010-12 | — |
Upsher-Smith Laboratories, LLC: common questions
- What is Upsher-Smith Laboratories, LLC's NDC labeler code?
- 0245, 0832, 24979, 80789. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Upsher-Smith Laboratories, LLC?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.